In the United States, ahead of Trump’s impending inauguration into the White House in January, many American women have shared on social media their concerns about access to abortion and care in the reproductive sphere. Meanwhile, they will stock up on emergency contraceptives and abortion pills before Trump takes office, and some are even planning to resort to IUD insertion and even sterilization.
As The Hill reports, providers of medication abortion services have reported a surge in requests and purchases of abortion drugs in the hours following Donald Trump’s election. Indeed, the concern is that the incoming administration, Congress, and Trump-appointed judges could restrict access.
Aid Access, a nonprofit organization that helps people gain access to the abortion pills mifepristone and misoprostol, said it had seen a more than 16-fold increase in requests for abortion drugs as early as the day after the election.
Cadence OTC, which assists in the field of emergency contraception by facilitating access to birth control pills, also reported a boom in purchases. Specifically, according to a spokesperson, it is five times the amount the company normally earns in a week, but has recorded in a single day.
Meanwhile, Wisp, a reproductive health care company, similarly saw a huge increase in requests for abortion pills and emergency contraception in the aftermath of the election.
Sales of emergency contraception increased by 1,000 percent among Wisp’s regular patients as of Nov. 6, according to company CEO Monica Cepak. In addition, among new Wisp patients, sales increased by 1,650 percent the day after the election.
